Roivant Sciences

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ROIV and other ETFs, options, and stocks.

About ROIV

Roivant Sciences Ltd. engages in the biopharmaceutical business, which engages in the development of transformative medicine. Its product portfolio includes Vtama, Batoclimab, Brepocitinib, Namilumab, and RVT-2001, which aims to treat psoriasis, atopic dermatitis, thyroid eye disease, and other illnesses.

CEO

Matthew Gline

CEOMatthew Gline

Employees

750

Employees750

Headquarters

London, Greater London

HeadquartersLondon, Greater London

Founded

2021

Founded2021

Employees

750

Employees750

ROIV Key Statistics

Market cap

8.67B

Market cap8.67B

Price-Earnings ratio

-18.02

Price-Earnings ratio-18.02

Dividend yield

—

Dividend yield—

Average volume

5.28M

Average volume5.28M

High today

$13.08

High today$13.08

Low today

$12.53

Low today$12.53

Open price

$12.57

Open price$12.57

Volume

6.68M

Volume6.68M

52 Week high

$13.08

52 Week high$13.08

52 Week low

$8.73

52 Week low$8.73

Analyst ratings

92%

of 12 ratings

Buy

91.7%

Hold

8.3%

Sell

People also own

Based on the portfolios of people who own ROIV. This list is generated using Robinhood data, and it’s not a recommendation.

Taiwan Semiconductor Manu…